The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory
UK Medical cannabis operator Grow Group has announced a significant expansion of its full-service UK medical cannabis distribution platform, as it launches the newly rebranded Grow Group UK.
This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process,
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
Cannabis possession for personal use should ‘no longer be a criminal offence’, recommends a highly anticipated report led by Lord Charlie Falconer QC.
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK.
New data acquired from the Home Office by Prohibition Partners and Business of Cannabis shows that since 2021, the UK has imported the bulk of its medical cannabis from Spain.
This story was first reported on Cannabis Health News. Hundreds of families in the UK are giving their children
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp.
Business of Cannabis recently sat down with Releaf’s Chief Operating Officer, Graham Woodward, a trained psychiatric nurse and former clinical director and CQC Specialist Advisor, to discuss the impact of the lack of access to training how clinics such as Releaf are working to change it.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion.
Grow Pharma and Integro Medical Clinics are set to expand their flagship medical cannabis access program to all UK university
We won’t spam you
